NEUROSCIENCE AND PAIN PRIORITY RESEARCH AREA A SNAPSHOT OF ACTIVITY
Crucial steps towards gene therapy for debilitating Meniere’s disease
The Kolling’s Meniere disease research team
Professor Lopez-Escamez said it was an exciting time for research in this area as we move into precision medicine with specific drugs and develop gene therapy for the next generation of patients with the disease, which causes vertigo and hearing loss.
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science, developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez- Escamez, who relocated from Spain to the institute to pursue his ground-breaking work.
28
Made with FlippingBook - professional solution for displaying marketing and sales documents online